Connable Office’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$1M Buy
11,626
+1,418
+14% +$125K 0.09% 92
2026
Q2
$799K Sell
10,208
-169
-2% -$13.6K 0.07% 107
2026
Q1
$899K Buy
+10,377
New +$994K 0.09% 93
2017
Q2
– Sell
-2,812
Closed -$227K – 179
2017
Q1
$227K Buy
+2,812
New +$220K 0.05% 154
2016
Q1
– Sell
-38,766
Closed -$2.98M – 187
2015
Q4
$2.98M Sell
38,766
-1,199
-3% -$90.3K 0.86% 30
2015
Q3
$2.68M Hold
39,965
– – 0.79% 27
2015
Q2
$2.96M Sell
39,965
-9,680
-19% -$740K 0.79% 34
2015
Q1
$3.87M Sell
49,645
-26
-0.1% -$1.97K 0.99% 19
2014
Q4
$3.59M Sell
49,671
-752
-1% -$52.2K 0.97% 20
2014
Q3
$3.12M Sell
50,423
-52
-0.1% -$3.31K 0.82% 30
2014
Q2
$3.22M Sell
50,475
-294
-0.6% -$17.9K 0.83% 29
2014
Q1
$3.12M Hold
50,769
– – 0.85% 32
2013
Q4
$2.91M Sell
50,769
-445
-0.9% -$25.2K 0.79% 35
2013
Q3
$2.73M Sell
51,214
-156
-0.3% -$8.39K 0.77% 35
2013
Q2
$2.64M Buy
+51,370
New +$2.54M 0.75% 33

Other funds holding MDT

Connable Office's MDT Position: Q3 2026 in Review

Connable Office increased its Medtronic (MDT) stake by 14% in Q3 2026, buying an estimated $125K and bringing the position to 11,626 shares worth $1M. The position accounts for 0.09% of the portfolio, ranked #92.

Connable Office first reported a position in MDT in Q2 2013 and has held it in 15 quarters since. The position peaked at $3.87M in Q1 2015. 1,900 funds tracked by Wall St. Rank hold MDT as of Q3 2026.

  • Connable Office held 11,626 shares of Medtronic worth $1M as of Q3 2026.
  • Connable Office bought 1,418 Medtronic shares in Q3 2026, an estimated $125K.
  • Medtronic made up 0.09% of Connable Office's portfolio in Q3 2026, its #92 holding.
  • Connable Office first reported a position in Medtronic in Q2 2013 and has held it in 15 quarters since.
  • Connable Office's Medtronic position peaked at $3.87M in Q1 2015.
  • 1,900 funds tracked by Wall St. Rank held Medtronic as of Q3 2026.

Based on Connable Office's 13F filing for Q3 2026, filed 10 Nov 2026.